powered by
▸
healthparse
Search
Cohort Builder
Tools
▾
KOL Finder
Territories
Drug Compare
AI Query
Browse
▾
By state
By specialty
Pricing
Search
Cohort Builder
Tools
KOL Finder
Territories
Drug Compare
AI Query
Browse
By state
By specialty
Pricing
PROVIDER PROFILE · NPI 1023279544
Michael Mohning
M.D.
Pulmonary Disease
Denver,
CO
I
CROSS-REFERENCE
Related data on other Healthparse brands
ProviderScore
OIG/SAM exclusion screening, sanctions history
FACILITY AFFILIATIONS
Hospital & Facility Affiliations (3)
CCN 060027
Hospital
CCN 060028
Hospital
CCN 060107
Hospital
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
231
Unique beneficiaries
—
Total services
290
Distinct HCPCS
4
Medicare payment
$29K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 178 Pulmonary Disease providers in CO — below median (cohort median 503).
QUALITY · MIPS · 2024
Final MIPS score
81.8
Quality
69.4
Cost
65.2
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
0.29%
Group
PRESCRIBING · PART D · 2024
Total Rx claims
552
Beneficiaries
—
Total drug cost
$1.7M
Distinct drugs
17
Brand share
68.5%
Top prescribed drugs
Nintedanib Esylate
100 claims
Prednisone
53 claims
Fluticasone Propion/Salmeterol
43 claims
Mycophenolate Mofetil
43 claims
Albuterol Sulfate
38 claims
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
Total received
$138
Payment records
1
By payment type
Food and Beverage
$138
